Share Price and Basic Stock Data
Last Updated: February 13, 2026, 9:00 pm
| PEG Ratio | 0.77 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Krishana Phoschem Ltd operates in the fertiliser industry, with its stock currently priced at ₹521 and a market capitalization of ₹3,153 Cr. The company has demonstrated significant revenue growth, with reported sales rising from ₹323 Cr in FY 2023 to ₹1,355 Cr in FY 2025, reflecting a compound annual growth rate (CAGR) of approximately 56.6%. The trailing twelve months (TTM) sales stood at ₹1,780 Cr. Quarterly sales figures illustrate a robust upward trajectory, with the most recent quarter (Sep 2023) recording sales of ₹265 Cr, a notable increase from ₹145 Cr in Mar 2023. This upward trend is further highlighted by the anticipated increase in sales, reaching ₹659 Cr by Dec 2025. Such growth can be attributed to strong demand in the agricultural sector, driven by increased awareness and adoption of modern agricultural practices, aligning with India’s push for food security and sustainable farming.
Profitability and Efficiency Metrics
Krishana Phoschem Ltd has reported impressive profitability metrics, with a net profit of ₹117 Cr and a return on equity (ROE) of 25.3%. The company’s operating profit margin (OPM) stood at 11%, with the operating profit increasing significantly from ₹52 Cr in FY 2023 to ₹184 Cr in FY 2025. The interest coverage ratio (ICR) is robust at 4.91x, indicating that the company can comfortably meet its interest obligations. However, the OPM has shown volatility, declining to 10% in Dec 2023, which may raise concerns regarding cost management amid rising input costs. The cash conversion cycle (CCC) is reported at 95 days, reflecting potential inefficiencies in inventory management and receivables collection. Comparatively, Krishana’s profitability metrics align well with industry standards, although continuous monitoring of operational efficiency is essential to maintain competitive advantage.
Balance Sheet Strength and Financial Ratios
The balance sheet of Krishana Phoschem Ltd reveals a total debt of ₹413 Cr against total reserves of ₹383 Cr, resulting in a debt-to-equity ratio of 0.97x, indicating a relatively leveraged position. Despite this, the return on capital employed (ROCE) is strong at 21.7%, demonstrating effective use of capital to generate profits. The current ratio stands at 1.41, suggesting sufficient liquidity to cover short-term obligations. The company’s book value per share has increased to ₹62.08 as of Mar 2025, reflecting a healthy net asset position. However, the significant rise in borrowings from ₹276 Cr in FY 2023 to ₹413 Cr in Sep 2025 raises concerns about financial risk, particularly in a rising interest rate environment. The interest coverage ratio, while strong, also signals that the company must manage its debt levels prudently to sustain its growth trajectory.
Shareholding Pattern and Investor Confidence
Krishana Phoschem’s shareholding pattern indicates a strong promoter shareholding of 71.96%, which enhances stability and investor confidence in the company. The proportion of foreign institutional investors (FIIs) has seen a marginal increase to 0.60%, suggesting cautious interest from external investors. The total number of shareholders has risen to 13,987, reflecting growing public interest and confidence in the company’s growth prospects. However, the declining public shareholding from 35.17% in Dec 2022 to 27.44% in Sep 2025 may indicate a consolidation of ownership among promoters, which could affect liquidity and market perception. The company has maintained a consistent dividend payout of ₹0.50 per share, which, while modest, signals a commitment to returning value to shareholders amidst significant capital reinvestment needs.
Outlook, Risks, and Final Insight
Looking ahead, Krishana Phoschem Ltd’s growth potential remains robust, driven by increasing agricultural demand and its strategic positioning within the fertiliser sector. However, risks include rising raw material costs, which could pressure margins, and the company’s high debt levels, which necessitate careful management to avoid financial strain. Additionally, fluctuations in agricultural commodity prices and regulatory changes could impact profitability. The company has opportunities to enhance operational efficiencies and expand its product offerings, which could further bolster growth. In scenarios where raw material prices stabilize and operational efficiencies improve, Krishana could see enhanced profit margins. Conversely, if input costs continue to rise or if agricultural demand falters, profitability could be adversely affected, necessitating a vigilant approach to risk management and strategic planning.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 6,936 Cr. | 174 | 221/156 | 10.0 | 313 | 2.87 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 134 Cr. | 25.4 | 55.0/23.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 101 Cr. | 11.2 | 17.9/9.27 | 17.2 | 20.0 | 0.45 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 993 Cr. | 236 | 395/155 | 2.99 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,415 Cr. | 69.5 | 128/68.5 | 7.02 | 63.8 | 2.88 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,118.19 Cr | 373.60 | 194.46 | 185.72 | 1.02% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 47 | 145 | 165 | 265 | 230 | 263 | 281 | 301 | 304 | 473 | 396 | 608 | 659 |
| Expenses | 38 | 127 | 133 | 218 | 207 | 238 | 239 | 260 | 260 | 417 | 330 | 535 | 589 |
| Operating Profit | 9 | 19 | 32 | 47 | 24 | 26 | 42 | 40 | 44 | 56 | 66 | 73 | 70 |
| OPM % | 18% | 13% | 20% | 18% | 10% | 10% | 15% | 13% | 15% | 12% | 17% | 12% | 11% |
| Other Income | 1 | 1 | 1 | -1 | 0 | 1 | 1 | 2 | 2 | 6 | 3 | 3 | 4 |
| Interest | 1 | 3 | 7 | 10 | 9 | 11 | 12 | 10 | 9 | 8 | 9 | 7 | 9 |
| Depreciation | 2 | 2 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 |
| Profit before tax | 6 | 14 | 18 | 28 | 6 | 7 | 23 | 25 | 29 | 47 | 51 | 61 | 57 |
| Tax % | 18% | 56% | 33% | 32% | 41% | 17% | 28% | 32% | 29% | 30% | 40% | 45% | 41% |
| Net Profit | 5 | 6 | 12 | 19 | 4 | 6 | 16 | 17 | 21 | 33 | 31 | 33 | 33 |
| EPS in Rs | 0.78 | 1.05 | 2.00 | 3.25 | 0.61 | 0.92 | 2.71 | 2.76 | 3.39 | 5.43 | 5.05 | 5.48 | 5.50 |
Last Updated: February 5, 2026, 6:10 am
Below is a detailed analysis of the quarterly data for Krishana Phoschem Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 659.00 Cr.. The value appears strong and on an upward trend. It has increased from 608.00 Cr. (Sep 2025) to 659.00 Cr., marking an increase of 51.00 Cr..
- For Expenses, as of Dec 2025, the value is 589.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 535.00 Cr. (Sep 2025) to 589.00 Cr., marking an increase of 54.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Sep 2025) to 70.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Dec 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Sep 2025) to 11.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Sep 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Dec 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Sep 2025) to 9.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Dec 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 9.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Sep 2025) to 57.00 Cr., marking a decrease of 4.00 Cr..
- For Tax %, as of Dec 2025, the value is 41.00%. The value appears to be improving (decreasing) as expected. It has decreased from 45.00% (Sep 2025) to 41.00%, marking a decrease of 4.00%.
- For Net Profit, as of Dec 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 33.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 5.50. The value appears strong and on an upward trend. It has increased from 5.48 (Sep 2025) to 5.50, marking an increase of 0.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 90 | 73 | 89 | 80 | 96 | 146 | 162 | 188 | 318 | 323 | 923 | 1,355 | 1,780 |
| Expenses | 75 | 63 | 77 | 64 | 77 | 112 | 127 | 149 | 263 | 271 | 795 | 1,171 | 1,541 |
| Operating Profit | 15 | 10 | 12 | 15 | 19 | 33 | 35 | 39 | 56 | 52 | 128 | 184 | 239 |
| OPM % | 17% | 13% | 13% | 19% | 20% | 23% | 22% | 21% | 17% | 16% | 14% | 14% | 13% |
| Other Income | 0 | 4 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 3 | 2 | 10 | 14 |
| Interest | 4 | 5 | 5 | 4 | 6 | 3 | 3 | 2 | 4 | 7 | 37 | 39 | 34 |
| Depreciation | 4 | 3 | 6 | 6 | 8 | 11 | 12 | 10 | 10 | 9 | 34 | 31 | 32 |
| Profit before tax | 8 | 5 | 3 | 6 | 6 | 19 | 21 | 28 | 43 | 39 | 59 | 123 | 188 |
| Tax % | 33% | 43% | 54% | 46% | 44% | 29% | 34% | 31% | 31% | 31% | 32% | 30% | |
| Net Profit | 5 | 3 | 1 | 3 | 4 | 14 | 14 | 20 | 29 | 27 | 40 | 87 | 117 |
| EPS in Rs | 1.40 | 0.70 | 0.33 | 0.66 | 0.71 | 2.71 | 2.77 | 3.75 | 4.97 | 4.51 | 6.68 | 14.29 | 19.35 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 7% | 5% | 6% | 8% | 4% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -40.00% | -66.67% | 200.00% | 33.33% | 250.00% | 0.00% | 42.86% | 45.00% | -6.90% | 48.15% | 117.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.67% | 266.67% | -166.67% | 216.67% | -250.00% | 42.86% | 2.14% | -51.90% | 55.04% | 69.35% |
Krishana Phoschem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 53% |
| 3 Years: | 62% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 44% |
| 3 Years: | 43% |
| TTM: | 124% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 81% |
| 3 Years: | 53% |
| 1 Year: | 120% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: December 10, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 21 | 21 | 25 | 25 | 25 | 25 | 26 | 30 | 31 | 62 | 62 | 62 |
| Reserves | 48 | 52 | 59 | 68 | 71 | 85 | 100 | 121 | 191 | 231 | 239 | 322 | 383 |
| Borrowings | 29 | 30 | 32 | 46 | 42 | 32 | 12 | 21 | 70 | 276 | 436 | 376 | 413 |
| Other Liabilities | 18 | 19 | 5 | 14 | 11 | 29 | 21 | 27 | 39 | 44 | 108 | 276 | 413 |
| Total Liabilities | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,270 |
| Fixed Assets | 74 | 72 | 72 | 80 | 112 | 106 | 96 | 94 | 85 | 358 | 322 | 295 | 280 |
| CWIP | 0 | 9 | 8 | 25 | 0 | 1 | 0 | 7 | 92 | 3 | 43 | 78 | 89 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 38 | 42 | 37 | 48 | 37 | 64 | 62 | 94 | 153 | 220 | 479 | 664 | 901 |
| Total Assets | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,270 |
Below is a detailed analysis of the balance sheet data for Krishana Phoschem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 62.00 Cr..
- For Reserves, as of Sep 2025, the value is 383.00 Cr.. The value appears strong and on an upward trend. It has increased from 322.00 Cr. (Mar 2025) to 383.00 Cr., marking an increase of 61.00 Cr..
- For Borrowings, as of Sep 2025, the value is 413.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 376.00 Cr. (Mar 2025) to 413.00 Cr., marking an increase of 37.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 276.00 Cr. (Mar 2025) to 413.00 Cr., marking an increase of 137.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,036.00 Cr. (Mar 2025) to 1,270.00 Cr., marking an increase of 234.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 280.00 Cr.. The value appears to be declining and may need further review. It has decreased from 295.00 Cr. (Mar 2025) to 280.00 Cr., marking a decrease of 15.00 Cr..
- For CWIP, as of Sep 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Mar 2025) to 89.00 Cr., marking an increase of 11.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 901.00 Cr.. The value appears strong and on an upward trend. It has increased from 664.00 Cr. (Mar 2025) to 901.00 Cr., marking an increase of 237.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,270.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,036.00 Cr. (Mar 2025) to 1,270.00 Cr., marking an increase of 234.00 Cr..
However, the Borrowings (413.00 Cr.) are higher than the Reserves (383.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -14.00 | -20.00 | -20.00 | -31.00 | -23.00 | 1.00 | 23.00 | 18.00 | -14.00 | -224.00 | -308.00 | -192.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 8 | 24 | 62 | 66 | 52 | 53 | 41 | 54 | 60 | 84 | 104 | 102 |
| Inventory Days | 223 | 290 | 97 | 224 | 127 | 157 | 135 | 145 | 103 | 194 | 84 | 60 |
| Days Payable | 72 | 115 | 20 | 94 | 43 | 85 | 22 | 41 | 39 | 16 | 35 | 67 |
| Cash Conversion Cycle | 159 | 200 | 139 | 195 | 136 | 126 | 154 | 158 | 124 | 263 | 154 | 95 |
| Working Capital Days | 17 | 36 | 49 | 57 | 22 | 52 | 87 | 95 | 95 | 64 | 44 | 42 |
| ROCE % | 14% | 11% | 7% | 8% | 9% | 16% | 17% | 20% | 20% | 11% | 15% | 22% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 14.00 | 6.54 | 8.80 | 10.50 | 7.83 |
| Diluted EPS (Rs.) | 14.00 | 6.54 | 8.65 | 10.42 | 7.15 |
| Cash EPS (Rs.) | 19.04 | 12.07 | 11.46 | 13.34 | 11.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Dividend / Share (Rs.) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Revenue From Operations / Share (Rs.) | 219.68 | 149.43 | 104.43 | 107.75 | 72.31 |
| PBDIT / Share (Rs.) | 31.36 | 21.02 | 17.61 | 19.20 | 15.68 |
| PBIT / Share (Rs.) | 26.32 | 15.50 | 14.80 | 15.80 | 11.75 |
| PBT / Share (Rs.) | 19.94 | 9.55 | 12.60 | 14.43 | 10.88 |
| Net Profit / Share (Rs.) | 14.00 | 6.54 | 8.65 | 9.94 | 7.50 |
| PBDIT Margin (%) | 14.27 | 14.06 | 16.86 | 17.81 | 21.67 |
| PBIT Margin (%) | 11.98 | 10.37 | 14.17 | 14.66 | 16.25 |
| PBT Margin (%) | 9.07 | 6.39 | 12.06 | 13.39 | 15.04 |
| Net Profit Margin (%) | 6.37 | 4.37 | 8.28 | 9.22 | 10.37 |
| Return on Networth / Equity (%) | 22.54 | 13.45 | 10.21 | 13.32 | 13.31 |
| Return on Capital Employeed (%) | 27.68 | 19.62 | 10.73 | 16.87 | 19.03 |
| Return On Assets (%) | 8.35 | 4.78 | 4.59 | 8.93 | 10.01 |
| Long Term Debt / Equity (X) | 0.34 | 0.52 | 0.55 | 0.22 | 0.04 |
| Total Debt / Equity (X) | 0.97 | 1.45 | 1.06 | 0.31 | 0.10 |
| Asset Turnover Ratio (%) | 1.44 | 1.29 | 0.70 | 1.22 | 1.07 |
| Current Ratio (X) | 1.41 | 1.33 | 1.36 | 2.58 | 2.43 |
| Quick Ratio (X) | 1.08 | 0.92 | 0.65 | 1.52 | 1.24 |
| Inventory Turnover Ratio (X) | 9.33 | 4.61 | 1.86 | 3.14 | 2.57 |
| Dividend Payout Ratio (NP) (%) | 3.57 | 3.82 | 5.54 | 4.64 | 6.35 |
| Dividend Payout Ratio (CP) (%) | 2.62 | 2.07 | 4.18 | 3.46 | 4.17 |
| Earning Retention Ratio (%) | 96.43 | 96.18 | 94.46 | 95.36 | 93.65 |
| Cash Earning Retention Ratio (%) | 97.38 | 97.93 | 95.82 | 96.54 | 95.83 |
| Interest Coverage Ratio (X) | 4.91 | 3.54 | 7.98 | 14.05 | 17.99 |
| Interest Coverage Ratio (Post Tax) (X) | 3.19 | 2.10 | 4.92 | 8.27 | 9.61 |
| Enterprise Value (Cr.) | 1801.75 | 1938.86 | 1779.52 | 892.61 | 259.52 |
| EV / Net Operating Revenue (X) | 1.33 | 2.10 | 5.51 | 2.79 | 1.38 |
| EV / EBITDA (X) | 9.29 | 14.92 | 32.69 | 15.69 | 6.34 |
| MarketCap / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| Retention Ratios (%) | 96.42 | 96.17 | 94.45 | 95.35 | 93.64 |
| Price / BV (X) | 3.79 | 5.02 | 5.74 | 3.73 | 1.66 |
| Price / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| EarningsYield | 0.05 | 0.02 | 0.01 | 0.03 | 0.08 |
After reviewing the key financial ratios for Krishana Phoschem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.04. This value is within the healthy range. It has increased from 12.07 (Mar 24) to 19.04, marking an increase of 6.97.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 219.68. It has increased from 149.43 (Mar 24) to 219.68, marking an increase of 70.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.36. This value is within the healthy range. It has increased from 21.02 (Mar 24) to 31.36, marking an increase of 10.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.32. This value is within the healthy range. It has increased from 15.50 (Mar 24) to 26.32, marking an increase of 10.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 19.94. This value is within the healthy range. It has increased from 9.55 (Mar 24) to 19.94, marking an increase of 10.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For PBDIT Margin (%), as of Mar 25, the value is 14.27. This value is within the healthy range. It has increased from 14.06 (Mar 24) to 14.27, marking an increase of 0.21.
- For PBIT Margin (%), as of Mar 25, the value is 11.98. This value is within the healthy range. It has increased from 10.37 (Mar 24) to 11.98, marking an increase of 1.61.
- For PBT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 6.39 (Mar 24) to 9.07, marking an increase of 2.68.
- For Net Profit Margin (%), as of Mar 25, the value is 6.37. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 6.37, marking an increase of 2.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.54. This value is within the healthy range. It has increased from 13.45 (Mar 24) to 22.54, marking an increase of 9.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 27.68. This value is within the healthy range. It has increased from 19.62 (Mar 24) to 27.68, marking an increase of 8.06.
- For Return On Assets (%), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 4.78 (Mar 24) to 8.35, marking an increase of 3.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.34, marking a decrease of 0.18.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 0.97, marking a decrease of 0.48.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.44. It has increased from 1.29 (Mar 24) to 1.44, marking an increase of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.33 (Mar 24) to 1.41, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.08, marking an increase of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 9.33, marking an increase of 4.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 20. It has decreased from 3.82 (Mar 24) to 3.57, marking a decrease of 0.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 20. It has increased from 2.07 (Mar 24) to 2.62, marking an increase of 0.55.
- For Earning Retention Ratio (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 70. It has increased from 96.18 (Mar 24) to 96.43, marking an increase of 0.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.38. This value exceeds the healthy maximum of 70. It has decreased from 97.93 (Mar 24) to 97.38, marking a decrease of 0.55.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.91. This value is within the healthy range. It has increased from 3.54 (Mar 24) to 4.91, marking an increase of 1.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.19. This value is within the healthy range. It has increased from 2.10 (Mar 24) to 3.19, marking an increase of 1.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,801.75. It has decreased from 1,938.86 (Mar 24) to 1,801.75, marking a decrease of 137.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 2.10 (Mar 24) to 1.33, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 14.92 (Mar 24) to 9.29, marking a decrease of 5.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For Retention Ratios (%), as of Mar 25, the value is 96.42. This value exceeds the healthy maximum of 70. It has increased from 96.17 (Mar 24) to 96.42, marking an increase of 0.25.
- For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 5.02 (Mar 24) to 3.79, marking a decrease of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Krishana Phoschem Ltd:
- Net Profit Margin: 6.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 27.68% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.54% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.9 (Industry average Stock P/E: 194.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.97
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Wing A/2, 1st Floor, Ostwal Heights, Urban Forest, Atun, Bhilwara Rajasthan 311802 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahendra Kumar Ostwal | Chairman & Non-Exe.Director |
| Mr. Praveen Ostwal | Managing Director |
| Mr. Sunil Kothari | WholeTime Director & CFO |
| Mr. Pankaj Ostwal | Non Executive Director |
| Mr. Bheru Lal Ostwal | Independent Director |
| Mrs. Shruti Babel | Independent Director |
| Mr. Gopal Inani | Independent Director |
| Mrs. Priyanka Surana | Independent Director |
FAQ
What is the intrinsic value of Krishana Phoschem Ltd?
Krishana Phoschem Ltd's intrinsic value (as of 16 February 2026) is ₹466.45 which is 8.90% lower the current market price of ₹512.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,103 Cr. market cap, FY2025-2026 high/low of ₹619/177, reserves of ₹383 Cr, and liabilities of ₹1,270 Cr.
What is the Market Cap of Krishana Phoschem Ltd?
The Market Cap of Krishana Phoschem Ltd is 3,103 Cr..
What is the current Stock Price of Krishana Phoschem Ltd as on 16 February 2026?
The current stock price of Krishana Phoschem Ltd as on 16 February 2026 is ₹512.
What is the High / Low of Krishana Phoschem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Krishana Phoschem Ltd stocks is ₹619/177.
What is the Stock P/E of Krishana Phoschem Ltd?
The Stock P/E of Krishana Phoschem Ltd is 23.9.
What is the Book Value of Krishana Phoschem Ltd?
The Book Value of Krishana Phoschem Ltd is 73.4.
What is the Dividend Yield of Krishana Phoschem Ltd?
The Dividend Yield of Krishana Phoschem Ltd is 0.10 %.
What is the ROCE of Krishana Phoschem Ltd?
The ROCE of Krishana Phoschem Ltd is 21.7 %.
What is the ROE of Krishana Phoschem Ltd?
The ROE of Krishana Phoschem Ltd is 25.3 %.
What is the Face Value of Krishana Phoschem Ltd?
The Face Value of Krishana Phoschem Ltd is 10.0.